Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds
Omnio, a Umeå-based BioTech startup, has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds toward clinical studies. This funding follows a €4.3 million financing round completed in spring 2025 to complete its GMP manufacturing process and move toward clinical trials. The company notes that the […]
